The global 1Deacetylbaccatin III market is expected to grow at a CAGR of XX% during the forecast period. The growth of this market can be attributed to the increasing demand for 1Deacetylbaccatin III in the production of docetaxel and paclitaxel. Docetaxel is used as an anticancer drug, which is prescribed for breast cancer, lung cancer, prostate cancer, and head and neck cancers. Paclitaxel is used as an anticancer drug that slows or stops tumor growth by preventing cells from dividing. It also helps to reduce pain and swelling caused by certain types of cancer.
Global 1Deacetylbaccatin III Market By Type (Greater than or equal to95%, Greater than or equal to98%), By Application (Production of Docetaxel, Production of Paclitaxel) And By Region (North America, Latin America, Europe, Asia Pacific And Middle East & Africa), Forecast From 2021 To 2030.
- Increasing prevalence of cancer and other chronic diseases will drive the growth of the 10-Deacetylbaccatin III market.
- Increasing awareness about the benefits of 10-Deacetylbaccatin III in various therapeutic areas will also fuel its growth in future years.
- The increasing number of clinical trials for 10-Deacetylbaccatin III will provide opportunities for new players to enter this market.
- The high cost associated with developing new drugs is a major restraint for this market.
Industry Growth Insights published a new data on “10-Deacetylbaccatin III Market”. The research report is titled “10-Deacetylbaccatin III Market research by Types (Greater than or equal to95%, Greater than or equal to98.0%, Others), By Applications (Production of Docetaxel, Production of Paclitaxel, Others), By Players/Companies SM Herbals, Alchem International, Indena, South Pharmaceutical, HAOXUAN, Yuannan Hande, Sai Phytoceuticals, Sarv Biolabs Pvt, Aphios, Hainan Yew Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
10-Deacetylbaccatin III Market Research Report
By Type
Greater than or equal to95%, Greater than or equal to98.0%, Others
By Application
Production of Docetaxel, Production of Paclitaxel, Others
By Companies
SM Herbals, Alchem International, Indena, South Pharmaceutical, HAOXUAN, Yuannan Hande, Sai Phytoceuticals, Sarv Biolabs Pvt, Aphios, Hainan Yew Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global 10-Deacetylbaccatin III Market Report Segments:
The global 10-Deacetylbaccatin III market is segmented on the basis of:
Types
Greater than or equal to95%, Greater than or equal to98.0%, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Production of Docetaxel, Production of Paclitaxel, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SM Herbals
- Alchem International
- Indena
- South Pharmaceutical
- HAOXUAN
- Yuannan Hande
- Sai Phytoceuticals
- Sarv Biolabs Pvt
- Aphios
- Hainan Yew Pharmaceutical
Highlights of The 10-Deacetylbaccatin III Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Greater than or equal to95%
- Greater than or equal to98.0%
- Others
- By Application:
- Production of Docetaxel
- Production of Paclitaxel
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 10-Deacetylbaccatin III Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
10-Deacetylbaccatin III is a synthetic compound that has been shown to have anti-cancer properties.
Some of the key players operating in the 10-deacetylbaccatin iii market are SM Herbals, Alchem International, Indena, South Pharmaceutical, HAOXUAN, Yuannan Hande, Sai Phytoceuticals, Sarv Biolabs Pvt, Aphios, Hainan Yew Pharmaceutical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. 10-Deacetylbaccatin III Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. 10-Deacetylbaccatin III Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. 10-Deacetylbaccatin III Market - Supply Chain
4.5. Global 10-Deacetylbaccatin III Market Forecast
4.5.1. 10-Deacetylbaccatin III Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. 10-Deacetylbaccatin III Market Size (000 Units) and Y-o-Y Growth
4.5.3. 10-Deacetylbaccatin III Market Absolute $ Opportunity
5. Global 10-Deacetylbaccatin III Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. 10-Deacetylbaccatin III Market Size and Volume Forecast by Type
5.3.1. Greater than or equal to95%
5.3.2. Greater than or equal to98.0%
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global 10-Deacetylbaccatin III Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. 10-Deacetylbaccatin III Market Size and Volume Forecast by Application
6.3.1. Production of Docetaxel
6.3.2. Production of Paclitaxel
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global 10-Deacetylbaccatin III Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. 10-Deacetylbaccatin III Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global 10-Deacetylbaccatin III Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. 10-Deacetylbaccatin III Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global 10-Deacetylbaccatin III Demand Share Forecast, 2019-2026
9. North America 10-Deacetylbaccatin III Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America 10-Deacetylbaccatin III Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America 10-Deacetylbaccatin III Market Size and Volume Forecast by Application
9.4.1. Production of Docetaxel
9.4.2. Production of Paclitaxel
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America 10-Deacetylbaccatin III Market Size and Volume Forecast by Type
9.7.1. Greater than or equal to95%
9.7.2. Greater than or equal to98.0%
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America 10-Deacetylbaccatin III Demand Share Forecast, 2019-2026
10. Latin America 10-Deacetylbaccatin III Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America 10-Deacetylbaccatin III Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America 10-Deacetylbaccatin III Market Size and Volume Forecast by Application
10.4.1. Production of Docetaxel
10.4.2. Production of Paclitaxel
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America 10-Deacetylbaccatin III Market Size and Volume Forecast by Type
10.7.1. Greater than or equal to95%
10.7.2. Greater than or equal to98.0%
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America 10-Deacetylbaccatin III Demand Share Forecast, 2019-2026
11. Europe 10-Deacetylbaccatin III Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe 10-Deacetylbaccatin III Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe 10-Deacetylbaccatin III Market Size and Volume Forecast by Application
11.4.1. Production of Docetaxel
11.4.2. Production of Paclitaxel
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe 10-Deacetylbaccatin III Market Size and Volume Forecast by Type
11.7.1. Greater than or equal to95%
11.7.2. Greater than or equal to98.0%
11.7.3. Others
11.8. Basis Point Shre (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe 10-Deacetylbaccatin III Demand Share, 2019-2026
12. Asia Pacific 10-Deacetylbaccatin III Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific 10-Deacetylbaccatin III Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific 10-Deacetylbaccatin III Market Size and Volume Forecast by Application
12.4.1. Production of Docetaxel
12.4.2. Production of Paclitaxel
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific 10-Deacetylbaccatin III Market Size and Volume Forecast by Type
12.7.1. Greater than or equal to95%
12.7.2. Greater than or equal to98.0%
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific 10-Deacetylbaccatin III Demand Share, 2019-2026
13. Middle East & Africa 10-Deacetylbaccatin III Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa 10-Deacetylbaccatin III Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa 10-Deacetylbaccatin III Market Size and Volume Forecast by Application
13.4.1. Production of Docetaxel
13.4.2. Production of Paclitaxel
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa 10-Deacetylbaccatin III Market Size and Volume Forecast by Type
13.7.1. Greater than or equal to95%
13.7.2. Greater than or equal to98.0%
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa 10-Deacetylbaccatin III Demand Share, 2019-2026
14. Competition Landscape
14.1. Global 10-Deacetylbaccatin III Market: Market Share Analysis
14.2. 10-Deacetylbaccatin III Distributors and Customers
14.3. 10-Deacetylbaccatin III Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. SM Herbals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alchem International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Indena
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. South Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. HAOXUAN
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Yuannan Hande
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sai Phytoceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sarv Biolabs Pvt
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Aphios
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hainan Yew Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
